Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Bernd Hutter has worked on the following 20 EPO patent applications which have been published in the last five years:

EP11791636

NOVEL ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS AND USES THEREOF

IPC classification:
C07K 7/14
Agent:
Cornelis Marinus Jansen, Vereenigde Octrooibureaux NV (V.O.)
Agent:
Bernd Hutter, MorphoSys AG
Status:
PATENT GRANTED
EP11790968

SIMULTANEOUS DETECTION OF BIOMOLECULES IN SINGLE CELLS

IPC classification:
C12Q 1/68, G01N 33/543, G01N 33/569, G01N 33/68
Applicant:
University of Freiburg (Albert-Ludwigs-Universit├Ąt Freiburg)
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
EXAMINATION IN PROGRESS
EP12733779

ANTIBODIES THAT ARE CROSS-REACTIVE FOR MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) AND D-DOPACHROME TAUTOMERASE (D-DT)

IPC classification:
C07K 16/24, C07K 16/40
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
GRANT OF PATENT INTENDED
EP12735555

USE OF C-FMS ANTAGONISTS

IPC classification:
A61K 39/395, A61P 19/02, A61P 25/04, C07K 16/24
Applicant:
MorphoSys AG
Applicant:
University of Melbourne
Agent:
Bernd Hutter, MorphoSys AG
Status:
PATENT GRANTED
EP11785411

A COLLECTION AND METHODS FOR ITS USE

IPC classification:
C07K 16/00, C12N 15/10
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
EXAMINATION IN PROGRESS
EP12747923

COMBINATION THERAPY WITH AN ANTI - CD19 ANTIBODY AND A NITROGEN MUSTARD

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
EXAMINATION IN PROGRESS
EP12745883

COMBINATION THERAPY WITH AN ANTI - CD19 ANTIBODY AND A PURINE ANALOG

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
EXAMINATION IN PROGRESS
EP12775247

ANTAGONISTS OF IL17C FOR THE TREATMENT OF INFLAMMATORY DISORDERS

IPC classification:
A61P 11/00, A61P 19/02, A61P 29/00, C07K 16/24
Applicant:
MorphoSys AG
Applicant:
Galapagos NV
Agent:
Bernd Hutter, MorphoSys AG
Status:
GRANT OF PATENT INTENDED
EP14164595

Generation and profiling of fully human HuCAL GOLD(RTM)-derived therapeutic antibodies specific for human CD38

IPC classification:
A61P 35/00, C07K 16/28
Applicant:
MorphoSys AG
Agent:
Jones Day
Agent:
Bernd Hutter, MorphoSys AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13700913

USE OF LYSOZYME AS A TAG

IPC classification:
C07K 1/22, C12N 15/62
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13752873

COMPLEX-SPECIFIC ANTIBODIES AND ANTIBODY FRAGMENTS AND ITS USE

IPC classification:
C07K 16/00, C07K 16/24, G01N 33/53, G01N 33/564
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
EXAMINATION IN PROGRESS
EP13766523

COMBINATIONS AND USES THEREOF

IPC classification:
A61K 31/195, A61K 39/395, A61P 35/00, C07K 16/28
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
EXAMINATION IN PROGRESS
EP13788728

RADIOLABELLED ANTIBODY AND USES THEREOF

IPC classification:
A61K 51/10, A61P 35/00
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
PATENT GRANTED
EP15151492

Anti-CD38 human antibodies and uses therefor

IPC classification:
A61P 37/00, C07K 16/28
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
EXAMINATION IN PROGRESS
EP13815739

ANTI-STAPHYLOCOCCAL ANTIBODIES

IPC classification:
C07K 16/12
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
GRANT OF PATENT INTENDED
EP14720512

ANTIBODIES TARGETING M-CSF

IPC classification:
C07K 16/24
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
EXAMINATION IN PROGRESS
EP14718555

ANTIBODIES TARGETING SPECIFICALLY HUMAN CXCR2

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
EXAMINATION REQUESTED
EP11736181

BACTERIAL SURFACE DISPLAY AND SCREENING OF THIOETHER-BRIDGE-CONTAINING PEPTIDES

IPC classification:
C12N 15/10, C12N 15/62
Applicant:
MorphoSys AG
Agent:
Cornelis Marinus Jansen, Vereenigde Octrooibureaux NV (V.O.)
Agent:
Bernd Hutter, MorphoSys AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11761360

ANTI-CD38 ANTIBODY AND LENALIDOMIDE OR BORTEZOMIB FOR THE TREATMENT OF MULTIPLE MYELOMA AND NHL

IPC classification:
A61K 31/454, A61K 31/69, A61K 38/05, A61K 38/07, A61K 39/395, A61K 45/06, A61P 35/00, C07K 16/28, C07K 16/30
Applicant:
MorphoSys AG
Agent:
Olga Bezzubova, Jones Day
Agent:
Bernd Hutter, MorphoSys AG
Status:
PATENT GRANTED
EP15720692

PEPTIDE LIBRARIES

IPC classification:
C07K 1/04, C12N 15/10, C40B 40/10, G01N 33/53
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature